Argus Investors Counsel’s Merck MRK Stock Holding History

Argus Investors Counsel’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,189	Closed	-$317K	–	118
2024 Q4	$317K	Buy	3,189 +1,097	+52%	+$113K	0.21%	105
2024 Q3	$238K	Sell	2,092 -791	-27%	-$94K	0.16%	110
2024 Q2	$357K	Buy	2,883 +1,050	+57%	+$135K	0.22%	98
2024 Q1	$242K	Buy	+1,833	New	+$226K	0.15%	104
2023 Q4	–	Sell	-9,629	Closed	-$991K	–	102
2023 Q3	$991K	Buy	9,629 +333	+4%	+$35.9K	0.71%	63
2023 Q2	$1.07M	Sell	9,296 -57	-0.6%	-$6.47K	0.74%	65
2023 Q1	$995K	Buy	+9,353	New	+$1.01M	0.75%	61
2020 Q3	–	Sell	-6,549	Closed	-$483K	–	78
2020 Q2	$483K	Buy	6,549 +1,288	+24%	+$97K	0.23%	68
2020 Q1	$386K	Buy	5,261 +198	+4%	+$15.6K	0.23%	63
2019 Q4	$439K	Buy	5,063 +449	+10%	+$36.9K	0.2%	65
2019 Q3	$371K	Buy	+4,614	New	+$370K	0.18%	67

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Argus Investors Counsel's MRK Position: Q1 2025 in Review

Argus Investors Counsel sold out of Merck (MRK) in Q1 2025, closing a stake of 3,189 shares — an estimated $317K sold.

Argus Investors Counsel first reported a position in MRK in Q3 2019 and held it in 11 quarters. The position peaked at $1.07M in Q2 2023. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

Argus Investors Counsel reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
Argus Investors Counsel sold 3,189 Merck shares in Q1 2025, an estimated $317K.
Argus Investors Counsel first reported a position in Merck in Q3 2019 and held it in 11 quarters.
Argus Investors Counsel's Merck position peaked at $1.07M in Q2 2023.
3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Argus Investors Counsel's 13F filing for Q1 2025, filed 16 Apr 2025.